pharma · Leukemia · Acute Myeloid Leukemia
Shanghai Medical College
Children's Hospital of Fudan University
Shanghai Medical College clinical programs — 9 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- CN
- Employees
- 20
- Programs
- 20
- Drugs
- 22
- Patents
- 0
Shanghai Medical College projects
9 ClinicalTrials.gov programs sponsored by Shanghai Medical College.
Shanghai Medical College has 9 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Asparaginase
Children's Hospital of Fudan University
Acute Myeloid Leukemia
1 trial -
Cisplatin
Children's Hospital of Fudan University
Localized Osteosarcoma
1 trial -
Cyclophosphamide
Children's Hospital of Fudan University
Stage III Kidney Wilms Tumor
1 trial -
Dactinomycin
Children's Hospital of Fudan University
Adult Kidney Wilms Tumor
1 trial -
asparaginase
Children's Hospital of Fudan University
Leukemia
2 trials -
cyclosporine
Children's Hospital of Fudan University
Graft Versus Host Disease
1 trial -
dactinomycin
Children's Hospital of Fudan University
Kidney Cancer
1 trial -
doxorubicin hydrochloride
Children's Hospital of Fudan University
Adult Alveolar Soft-part Sarcoma
1 trial -
filgrastim
Children's Hospital of Fudan University
Neuroblastoma
1 trial
Frequently asked questions
How many clinical projects does Shanghai Medical College have?
9 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.